[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Caffeine.]
[N03AX03, sulthiame, Sulthiame may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DA01, tacrine, The metabolism of Tacrine can be decreased when combined with Caffeine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Caffeine.]
[N05CD07, temazepam, The therapeutic efficacy of Temazepam can be decreased when used in combination with Caffeine.]
[L01CB02, teniposide, Caffeine may decrease the excretion rate of Teniposide which could result in a higher serum level.]
[R03CC03, terbutaline, The risk or severity of adverse effects can be increased when Terbutaline is combined with Caffeine.]
[G03BA03, testosterone, Caffeine may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[A04AD10, dronabinol, The metabolism of Caffeine can be decreased when combined with Dronabinol.]
[R03DA07, theobromine, The metabolism of Theobromine can be decreased when combined with Caffeine.]
[R03DA04, theophylline, The risk or severity of adverse effects can be increased when Caffeine is combined with Theophylline.]
[P02CA02, thiabendazole, The metabolism of Caffeine can be decreased when combined with Thiabendazole.]
[N05CA19, thiopental, The serum concentration of Caffeine can be decreased when it is combined with Thiopental.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be decreased when combined with Caffeine.]
[B01AC05, ticlopidine, The metabolism of Caffeine can be decreased when combined with Ticlopidine.]
[S01ED01, timolol, The risk or severity of adverse effects can be increased when Timolol is combined with Caffeine.]
[C03DB02, triamterene, The metabolism of Triamterene can be decreased when combined with Caffeine.]
[N05CD05, triazolam, The therapeutic efficacy of Triazolam can be decreased when used in combination with Caffeine.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be decreased when combined with Caffeine.]
[N03AC02, trimethadione, Trimethadione may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA08, troleandomycin, The metabolism of Caffeine can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, The serum concentration of Roflumilast can be increased when it is combined with Caffeine.]
[L02BX03, abiraterone, The serum concentration of Caffeine can be increased when it is combined with Abiraterone.]
[N03AX21, ezogabine, Ezogabine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AF01, rivaroxaban, Caffeine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The risk or severity of adverse effects can be increased when Caffeine is combined with Indacaterol.]
[C08DA01, verapamil, The metabolism of Verapamil can be decreased when combined with Caffeine.]
[N06AX09, viloxazine, The metabolism of Caffeine can be decreased when combined with Viloxazine.]
[L01CA02, vincristine, Caffeine may decrease the excretion rate of Vincristine which could result in a higher serum level.]
[B01AA03, warfarin, The metabolism of Warfarin can be decreased when combined with Caffeine.]
[J05AF01, zidovudine, Caffeine may decrease the excretion rate of Zidovudine which could result in a higher serum level.]
[N03AX14, levetiracetam, Levetiracetam may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EC01, vemurafenib, The serum concentration of Caffeine can be increased when it is combined with Vemurafenib.]
[R03DC01, zafirlukast, The serum concentration of Zafirlukast can be decreased when it is combined with Caffeine.]
[J01MA13, trovafloxacin, The metabolism of Caffeine can be decreased when combined with Trovafloxacin.]
[C07AB03, atenolol, The risk or severity of adverse effects can be increased when Atenolol is combined with Caffeine.]
[L03AB11, peginterferon alfa-2a, The metabolism of Caffeine can be decreased when combined with Peginterferon alfa-2a.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Caffeine.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be decreased when combined with Caffeine.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Caffeine.]
[L04AA31, teriflunomide, The serum concentration of Caffeine can be decreased when it is combined with Teriflunomide.]
[N05CA04, barbital, The serum concentration of Caffeine can be decreased when it is combined with Barbital.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be decreased when combined with Caffeine.]
[N04BD02, rasagiline, The metabolism of Rasagiline can be decreased when combined with Caffeine.]
[N06DA02, donepezil, Caffeine may decrease the excretion rate of Donepezil which could result in a higher serum level.]
[N03AX22, perampanel, The metabolism of Perampanel can be decreased when combined with Caffeine.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be decreased when combined with Caffeine.]
[L01EA05, ponatinib, Caffeine may decrease the excretion rate of Ponatinib which could result in a higher serum level.]
[B01AF02, apixaban, Caffeine may decrease the excretion rate of Apixaban which could result in a higher serum level.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Caffeine.]
[J01MA15, gemifloxacin, The metabolism of Caffeine can be decreased when combined with Gemifloxacin.]
[S01AE07, moxifloxacin, The metabolism of Caffeine can be decreased when combined with Moxifloxacin.]
[A06AX06, tegaserod, Caffeine may decrease the excretion rate of Tegaserod which could result in a higher serum level.]
[H03AA04, tiratricol, Tiratricol may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Caffeine.]
[M01AH01, celecoxib, Caffeine may decrease the excretion rate of Celecoxib which could result in a higher serum level.]
[L04AA18, everolimus, The metabolism of Caffeine can be decreased when combined with Everolimus.]
[L03AB03, gamma-interferon, The metabolism of Caffeine can be decreased when combined with Interferon Gamma.]
[L01EC02, dabrafenib, Caffeine may decrease the excretion rate of Dabrafenib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Caffeine.]
[L01EB03, afatinib, Caffeine may decrease the excretion rate of Afatinib which could result in a higher serum level.]
[J05AJ03, dolutegravir, Caffeine may decrease the excretion rate of Dolutegravir which could result in a higher serum level.]
[C02KX05, riociguat, Caffeine may increase the hypotensive activities of Riociguat.]
[N03AF04, eslicarbazepine, Eslicarbazepine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AP05, simeprevir, The metabolism of Caffeine can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Caffeine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[N03AG04, vigabatrin, Vigabatrin may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Caffeine.]
[C01CA27, droxidopa, The risk or severity of hypokalemia can be increased when Caffeine is combined with Droxidopa.]
[C07AB04, acebutolol, The risk or severity of adverse effects can be increased when Acebutolol is combined with Caffeine.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Caffeine.]
[L04AA32, apremilast, The metabolism of Caffeine can be increased when combined with Apremilast.]
[S01ED02, betaxolol, The risk or severity of adverse effects can be increased when Betaxolol is combined with Caffeine.]
[L04AC11, siltuximab, The metabolism of Caffeine can be increased when combined with Siltuximab.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Caffeine.]
[L01XH04, belinostat, The metabolism of Caffeine can be increased when combined with Belinostat.]
[L01EM01, idelalisib, Caffeine may decrease the excretion rate of Idelalisib which could result in a higher serum level.]
[R03AC19, olodaterol, Caffeine may increase the hyperkalemic activities of Olodaterol.]
[L03AB13, peginterferon beta-1a, The metabolism of Caffeine can be decreased when combined with Peginterferon beta-1a.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Caffeine.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Caffeine.]
[L04AC10, secukinumab, The metabolism of Caffeine can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, Caffeine may decrease the excretion rate of Palbociclib which could result in a higher serum level.]
[L01EX08, lenvatinib, Caffeine may decrease the excretion rate of Lenvatinib which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EB04, osimertinib, The serum concentration of Caffeine can be decreased when it is combined with Osimertinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Caffeine.]
[N03AX23, brivaracetam, Brivaracetam may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XX52, venetoclax, Caffeine may decrease the excretion rate of Venetoclax which could result in a higher serum level.]
[N05BA08, bromazepam, The therapeutic efficacy of Bromazepam can be decreased when used in combination with Caffeine.]
[A05AA04, obeticholic acid, The metabolism of Caffeine can be decreased when combined with Obeticholic acid.]
[N01BB01, bupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Caffeine.]
[C07AA19, bupranolol, The risk or severity of adverse effects can be increased when Bupranolol is combined with Caffeine.]
[J01MA09, sparfloxacin, The metabolism of Caffeine can be decreased when combined with Sparfloxacin.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Caffeine.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Caffeine.]
[R03CC12, bambuterol, The risk or severity of hypokalemia can be increased when Caffeine is combined with Bambuterol.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be decreased when combined with Caffeine.]
[N02BF02, pregabalin, Pregabalin may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AX30, beclamide, Beclamide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MB04, pipemidic acid, The metabolism of Caffeine can be decreased when combined with Pipemidic acid.]
[H03BA03, benzylthiouracil, Benzylthiouracil may decrease the excretion rate of Caffeine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Caffeine can be increased when combined with Infliximab.]
[L01ED04, brigatinib, Caffeine may decrease the excretion rate of Brigatinib which could result in a higher serum level.]
[J01MA23, delafloxacin, The metabolism of Caffeine can be decreased when combined with Delafloxacin.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Caffeine.]
[L01EM02, copanlisib, Caffeine may decrease the excretion rate of Copanlisib which could result in a higher serum level.]
[L01EF03, abemaciclib, Caffeine may decrease the excretion rate of Abemaciclib which could result in a higher serum level.]
[C07AB07, bisoprolol, The risk or severity of adverse effects can be increased when Bisoprolol is combined with Caffeine.]
[R03AC17, bitolterol, The risk or severity of hypokalemia can be increased when Caffeine is combined with Bitolterol.]
[J05AG03, efavirenz, The metabolism of Efavirenz can be decreased when combined with Caffeine.]
[C07AA17, bopindolol, The risk or severity of adverse effects can be increased when Bopindolol is combined with Caffeine.]
[N05CD09, brotizolam, The therapeutic efficacy of Brotizolam can be decreased when used in combination with Caffeine.]
[N01BX04, capsaicin, The metabolism of Capsaicin can be decreased when combined with Caffeine.]
[A10BK04, ertugliflozin, Caffeine may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.]
[N03AF01, carbamazepine, The serum concentration of Caffeine can be decreased when it is combined with Carbamazepine.]
[H03BB01, carbimazole, Carbimazole may decrease the excretion rate of Caffeine which could result in a higher serum level.]
[L03AB06, interferon alfa-n1, The metabolism of Caffeine can be decreased when combined with Interferon alfa-n1.]
[C07AG02, carvedilol, The risk or severity of adverse effects can be increased when Carvedilol is combined with Caffeine.]
[N03AX24, cannabidiol, Cannabidiol may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be decreased when combined with Caffeine.]
[C07AB08, celiprolol, The risk or severity of adverse effects can be increased when Celiprolol is combined with Caffeine.]
[N03AX17, stiripentol, The metabolism of Stiripentol can be decreased when combined with Caffeine.]
[B02BX07, lusutrombopag, Caffeine may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.]
[L01EM04, duvelisib, Caffeine may decrease the excretion rate of Duvelisib which could result in a higher serum level.]
[L01EB07, dacomitinib, Caffeine may decrease the excretion rate of Dacomitinib which could result in a higher serum level.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be decreased when combined with Caffeine.]
[L01XK04, talazoparib, Caffeine may decrease the excretion rate of Talazoparib which could result in a higher serum level.]
[R03BB08, revefenacin, Caffeine may decrease the excretion rate of Revefenacin which could result in a higher serum level.]
[L04AA39, emapalumab, The metabolism of Caffeine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, The metabolism of Carmustine can be decreased when combined with Caffeine.]
[L01XJ03, glasdegib, Caffeine may decrease the excretion rate of Glasdegib which could result in a higher serum level.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Caffeine.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Caffeine.]
[J01FA09, clarithromycin, The metabolism of Caffeine can be decreased when combined with Clarithromycin.]
[N06AX29, brexanolone, Brexanolone may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA09, clobazam, The therapeutic efficacy of Clobazam can be decreased when used in combination with Caffeine.]
[N05BA22, cloxazolam, The therapeutic efficacy of Cloxazolam can be decreased when used in combination with Caffeine.]
[L04AB01, etanercept, The metabolism of Caffeine can be increased when combined with Etanercept.]
[L01EM03, alpelisib, The serum concentration of Alpelisib can be increased when it is combined with Caffeine.]
[L02BB06, darolutamide, Caffeine may decrease the excretion rate of Darolutamide which could result in a higher serum level.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be decreased when combined with Caffeine.]
[N07XX11, pitolisant, The metabolism of Caffeine can be increased when combined with Pitolisant.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Caffeine.]
[A10AE03, insulin, regular, pork, The metabolism of Caffeine can be increased when combined with Insulin pork.]
[N03AX25, cenobamate, Cenobamate may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX16, givosiran, The serum concentration of Caffeine can be increased when it is combined with Givosiran.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Caffeine.]
[L01XX72, tazemetostat, Caffeine may decrease the excretion rate of Tazemetostat which could result in a higher serum level.]
[M01AX21, diacetylrhein, The metabolism of Caffeine can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Caffeine.]
[S01AE06, gatifloxacin, The metabolism of Caffeine can be decreased when combined with Gatifloxacin.]
[H02CA02, osilodrostat, The metabolism of Caffeine can be decreased when combined with Osilodrostat.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be decreased when combined with Caffeine.]
[L04AA38, ozanimod, Caffeine may decrease the excretion rate of Ozanimod which could result in a higher serum level.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Caffeine.]
[M01AH02, rofecoxib, The serum concentration of Caffeine can be increased when it is combined with Rofecoxib.]
[S01EA02, dipivefrin, The risk or severity of hypokalemia can be increased when Caffeine is combined with Dipivefrin.]
[N03AG02, dipropylacetamide, Valpromide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA13, dirithromycin, The metabolism of Caffeine can be decreased when combined with Dirithromycin.]
[N05BA02, chlordiazepoxide, The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Caffeine.]
[L01EH03, tucatinib, Caffeine may decrease the excretion rate of Tucatinib which could result in a higher serum level.]
[L01EX17, capmatinib, The metabolism of Caffeine can be decreased when combined with Capmatinib.]
[L01EX19, ripretinib, Caffeine may decrease the excretion rate of Ripretinib which could result in a higher serum level.]
[N05CM02, chlormethiazole, Clomethiazole may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AX29, fostemsavir, Caffeine may decrease the excretion rate of Fostemsavir which could result in a higher serum level.]
[N05CD14, remimazolam, The therapeutic efficacy of Remimazolam can be decreased when used in combination with Caffeine.]
[L04AC19, satralizumab, The serum concentration of Caffeine can be decreased when it is combined with Satralizumab.]
[L01EX23, pralsetinib, Caffeine may decrease the excretion rate of Pralsetinib which could result in a higher serum level.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be decreased when combined with Caffeine.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Caffeine.]
[N06BX18, vinpocetine, Vinpocetine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA18, ethyl loflazepate, The therapeutic efficacy of Ethyl loflazepate can be decreased when used in combination with Caffeine.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Caffeine.]
[P03AX07, abametapir, The serum concentration of Caffeine can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, Caffeine may decrease the excretion rate of Trilaciclib which could result in a higher serum level.]
[N03AX10, felbamate, Felbamate may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be decreased when combined with Caffeine.]
[N06BA08, fenozolone, The risk or severity of adverse effects can be increased when Fenozolone is combined with Caffeine.]
[J01MB07, flumequine, The metabolism of Caffeine can be decreased when combined with Flumequine.]
[R03CC15, formoterol, The risk or severity of hypokalemia can be increased when Caffeine is combined with Formoterol.]
[L03AB10, peginterferon alfa-2b, The serum concentration of Caffeine can be increased when it is combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The metabolism of Caffeine can be decreased when combined with Cimetidine.]
[N02BF01, gabapentin, Gabapentin may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Caffeine.]
[J01MB06, cinoxacin, The metabolism of Caffeine can be decreased when combined with Cinoxacin.]
[S03AA07, ciprofloxacin, The serum concentration of Caffeine can be increased when it is combined with Ciprofloxacin.]
[N06AB04, citalopram, The metabolism of Caffeine can be decreased when combined with Citalopram.]
[H01AC07, somapacitan, The metabolism of Caffeine can be increased when combined with Somapacitan.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be decreased when combined with Caffeine.]
[H01AC09, lonapegsomatropin, The metabolism of Caffeine can be increased when combined with Lonapegsomatropin.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be decreased when combined with Caffeine.]
[R03CC13, clenbuterol, The risk or severity of adverse effects can be increased when Clenbuterol is combined with Caffeine.]
[J01FF01, clindamycin, The metabolism of Caffeine can be decreased when combined with Clindamycin.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Caffeine can be decreased when combined with Ropeginterferon alfa-2b.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be decreased when combined with Caffeine.]
[L01EJ03, pacritinib, The metabolism of Caffeine can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Caffeine.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Caffeine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Caffeine.]
[N05BA21, clotiazepam, The therapeutic efficacy of Clotiazepam can be decreased when used in combination with Caffeine.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Caffeine.]
[N05AH02, clozapine, The metabolism of Clozapine can be decreased when combined with Caffeine.]
[N05BA13, halazepam, The therapeutic efficacy of Halazepam can be decreased when used in combination with Caffeine.]
[H01AC08, somatrogon, The metabolism of Caffeine can be increased when combined with Somatrogon.]
[L04AC21, bimekizumab, The metabolism of Caffeine can be increased when combined with Bimekizumab.]
[L04AA13, leflunomide, The serum concentration of Caffeine can be decreased when it is combined with Leflunomide.]
[C04AX28, ifenprodil, Ifenprodil may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be decreased when combined with Caffeine.]
[N05BA10, ketazolam, The therapeutic efficacy of Ketazolam can be decreased when used in combination with Caffeine.]
[L01EA01, imatinib, The metabolism of Imatinib can be decreased when combined with Caffeine.]
[N03AX09, lamotrigine, Lamotrigine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Caffeine.]
[S01AE04, lomefloxacin, The metabolism of Caffeine can be decreased when combined with Lomefloxacin.]
[N05CD06, lormetazepam, The therapeutic efficacy of Lormetazepam can be decreased when used in combination with Caffeine.]
[A08AA09, mefenorex, The risk or severity of adverse effects can be increased when Mefenorex is combined with Caffeine.]
[C07AA14, mepindolol, The risk or severity of adverse effects can be increased when Mepindolol is combined with Caffeine.]
[C01EB10, adenosine, The therapeutic efficacy of Adenosine can be decreased when used in combination with Caffeine.]
[R03CB02, methoxyphenamine, The risk or severity of adverse effects can be increased when Methoxyphenamine is combined with Caffeine.]
[J01FA03, midecamycin, The metabolism of Caffeine can be decreased when combined with Midecamycin.]
[N06BA07, modafinil, The metabolism of Caffeine can be increased when combined with Armodafinil.]
[C10AA07, rosuvastatin, Caffeine may decrease the excretion rate of Rosuvastatin which could result in a higher serum level.]
[J05AF10, entecavir, The metabolism of Entecavir can be decreased when combined with Caffeine.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be decreased when combined with Caffeine.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be decreased when combined with Caffeine.]
[L01DA01, dactinomycin, Caffeine may decrease the excretion rate of Dactinomycin which could result in a higher serum level.]
[L01DB02, daunorubicin, Caffeine may decrease the excretion rate of Daunorubicin which could result in a higher serum level.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be decreased when combined with Caffeine.]
[N05BA16, nordazepam, The therapeutic efficacy of Nordazepam can be decreased when used in combination with Caffeine.]
[C07AB12, nebivolol, The risk or severity of adverse effects can be increased when Nebivolol is combined with Caffeine.]
[N03AG06, tiagabine, Tiagabine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be decreased when combined with Caffeine.]
[L01XA03, oxaliplatin, Caffeine may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.]
[N03AF02, oxcarbazepine, Oxcarbazepine may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Caffeine.]
[L04AB04, adalimumab, The serum concentration of Caffeine can be decreased when it is combined with Adalimumab.]
[L01EB01, gefitinib, Caffeine may decrease the excretion rate of Gefitinib which could result in a higher serum level.]
[N06BA02, dextroamphetamine, The risk or severity of adverse effects can be increased when Amphetamine is combined with Caffeine.]
[N03AC01, paramethadione, Paramethadione may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Caffeine.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be decreased when combined with Caffeine.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be decreased when combined with Caffeine.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be decreased when used in combination with Caffeine.]
[N03AX07, phenacemide, Phenacemide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AD02, phensuximide, Phensuximide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be decreased when combined with Caffeine.]
[L01DC04, ixabepilone, The metabolism of Caffeine can be decreased when combined with Ixabepilone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Caffeine.]
[R03CC07, pirbuterol, The risk or severity of hypokalemia can be increased when Caffeine is combined with Pirbuterol.]
[A08AA03, diethylpropion, The risk or severity of adverse effects can be increased when Diethylpropion is combined with Caffeine.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be decreased when combined with Caffeine.]
[C10AX09, ezetimibe, Caffeine may decrease the excretion rate of Ezetimibe which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Caffeine can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Potassium perchlorate may decrease the excretion rate of Caffeine which could result in a higher serum level.]
[R03CC08, procaterol, The risk or severity of adverse effects can be increased when Procaterol is combined with Caffeine.]
[N03AG05, progabide, Progabide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be decreased when combined with Caffeine.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be decreased when combined with Caffeine.]
[N05CD10, quazepam, The therapeutic efficacy of Quazepam can be decreased when used in combination with Caffeine.]
[S01XA23, sirolimus, The metabolism of Caffeine can be decreased when combined with Sirolimus.]
[C01BA03, disopyramide, The metabolism of Disopyramide can be decreased when combined with Caffeine.]
[P03AA04, disulfiram, The serum concentration of Caffeine can be increased when it is combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Caffeine can be decreased when combined with Rifamycin.]
[N07XX02, riluzole, The metabolism of Riluzole can be decreased when combined with Caffeine.]
[N01BB09, ropivacaine, The metabolism of Ropivacaine can be decreased when combined with Caffeine.]
[J01MB01, rosoxacin, The metabolism of Caffeine can be decreased when combined with Rosoxacin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Caffeine.]
[R03AC12, salmeterol, The risk or severity of hypokalemia can be increased when Caffeine is combined with Salmeterol.]
[C01CA07, dobutamine, The risk or severity of adverse effects can be increased when Dobutamine is combined with Caffeine.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Caffeine.]
[C01CA04, dopamine, The risk or severity of adverse effects can be increased when Dopamine is combined with Caffeine.]
[N06AA16, dothiepin, The metabolism of Caffeine can be decreased when combined with Dosulepin.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Caffeine.]
[L01DB01, doxorubicin, Caffeine may decrease the excretion rate of Doxorubicin which could result in a higher serum level.]
[N02CC01, sumatriptan, Caffeine may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[C07AB13, talinolol, The risk or severity of adverse effects can be increased when Talinolol is combined with Caffeine.]
[J01MA05, temafloxacin, The metabolism of Caffeine can be decreased when combined with Temafloxacin.]
[D01BA02, terbinafine, The metabolism of Terbinafine can be decreased when combined with Caffeine.]
[C07AA16, tertatolol, The risk or severity of adverse effects can be increased when Tertatolol is combined with Caffeine.]
[S01GA02, tetrahydrozoline, The risk or severity of adverse effects can be increased when Tetryzoline is combined with Caffeine.]
[N03AX11, topiramate, Topiramate may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[R01AA09, tramazoline, The risk or severity of adverse effects can be increased when Tramazoline is combined with Caffeine.]
[N05CD11, triazulenone, The therapeutic efficacy of Loprazolam can be decreased when used in combination with Caffeine.]
[J01MA04, enoxacin, The metabolism of Caffeine can be decreased when combined with Enoxacin.]
[S01FB02, ephedrine, The risk or severity of adverse effects can be increased when Ephedrine is combined with Caffeine.]
[S01EA01, epinephrine, The risk or severity of adverse effects can be increased when Epinephrine is combined with Caffeine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Caffeine.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX11, zotepine, The metabolism of Zotepine can be decreased when combined with Caffeine.]
[S01AA17, erythromycin, The metabolism of Caffeine can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Caffeine.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be decreased when combined with Caffeine.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Caffeine.]
[G03CA57, estrogens, conjugated (USP), The metabolism of Conjugated estrogens can be decreased when combined with Caffeine.]
[J04AK02, ethambutol, The metabolism of Caffeine can be decreased when combined with Ethambutol.]
[C01CA15, gepefrine, The risk or severity of adverse effects can be increased when Gepefrine is combined with Caffeine.]
[L02AA03, ethinyl estradiol, The metabolism of Ethinylestradiol can be decreased when combined with Caffeine.]
[N03AD01, ethosuximide, Ethosuximide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AB01, ethotoin, Ethotoin may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA01, etilefrine, The risk or severity of adverse effects can be increased when Etilefrine is combined with Caffeine.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Caffeine.]
[J01MA08, fleroxacin, The metabolism of Caffeine can be decreased when combined with Fleroxacin.]
[N06AB08, fluvoxamine, The metabolism of Caffeine can be decreased when combined with Fluvoxamine.]
[C01BB03, tocainide, The metabolism of Tocainide can be decreased when combined with Caffeine.]
[C10AA03, pravastatin, Caffeine may decrease the excretion rate of Pravastatin which could result in a higher serum level.]
[A02BA03, famotidine, The metabolism of Caffeine can be decreased when combined with Famotidine.]
[P02CA03, albendazole, The metabolism of Caffeine can be increased when combined with Albendazole.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Caffeine.]
[R03CC04, fenoterol, The risk or severity of adverse effects can be increased when Fenoterol is combined with Caffeine.]
[R03CC02, albuterol, The risk or severity of hypokalemia can be increased when Caffeine is combined with Salbutamol.]
[L03AB02, interferon-beta, The metabolism of Caffeine can be decreased when combined with Human interferon beta.]
[L01BB06, clofarabine, Caffeine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, Caffeine may decrease the excretion rate of Cladribine which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Caffeine.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Caffeine.]
[N05CD03, flunitrazepam, The therapeutic efficacy of Flunitrazepam can be decreased when used in combination with Caffeine.]
[V03AZ01, ethanol, The metabolism of Ethanol can be decreased when combined with Caffeine.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Caffeine.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be decreased when combined with Caffeine.]
[N05CD01, flurazepam, The therapeutic efficacy of Flurazepam can be decreased when used in combination with Caffeine.]
[L02BB01, flutamide, The metabolism of Flutamide can be decreased when combined with Caffeine.]
[V04CX02, folic acid, Caffeine may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Caffeine.]
[N03AA04, barbexaclone, The serum concentration of Caffeine can be decreased when it is combined with Barbexaclone.]
[C10AB04, gemfibrozil, The metabolism of Caffeine can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Caffeine.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be decreased when combined with Caffeine.]
[N03AD03, methsuximide, Methsuximide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[A10BB01, glyburide, Caffeine may decrease the excretion rate of Glyburide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The metabolism of Caffeine can be decreased when combined with Dexmedetomidine.]
[H01AB01, thyrotropin alfa, Thyrotropin alfa may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Caffeine.]
[C07AB09, esmolol, The risk or severity of adverse effects can be increased when Esmolol is combined with Caffeine.]
[N05AD01, haloperidol, The metabolism of Haloperidol can be decreased when combined with Caffeine.]
[L01CE02, irinotecan, Caffeine may decrease the excretion rate of Irinotecan which could result in a higher serum level.]
[M04AA01, allopurinol, The serum concentration of Caffeine can be increased when it is combined with Allopurinol.]
[N05CA16, hexobarbital, The serum concentration of Caffeine can be decreased when it is combined with Hexobarbital.]
[R03CC05, hexoprenaline, The risk or severity of hypokalemia can be increased when Caffeine is combined with Hexoprenaline.]
[J05AG01, nevirapine, The metabolism of Caffeine can be decreased when combined with Nevirapine.]
[H01AC02, somatrem, The metabolism of Caffeine can be increased when combined with Somatrem.]
[N06AA02, imipramine, The metabolism of Imipramine can be decreased when combined with Caffeine.]
[M03BX02, tizanidine, The serum concentration of Tizanidine can be increased when it is combined with Caffeine.]
[L01CE01, topotecan, Caffeine may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[L03AB04, interferon alfa-2a, The metabolism of Caffeine can be decreased when combined with Interferon alfa-2a.]
[L03AB05, interferon alfa-2b, The metabolism of Caffeine can be decreased when combined with Interferon alfa-2b.]
[N05BA12, alprazolam, The therapeutic efficacy of Alprazolam can be decreased when used in combination with Caffeine.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be decreased when combined with Caffeine.]
[C10AA06, cerivastatin, Caffeine may decrease the excretion rate of Cerivastatin which could result in a higher serum level.]
[L01XX35, anagrelide, The metabolism of Anagrelide can be decreased when combined with Caffeine.]
[C07AA01, alprenolol, The risk or severity of adverse effects can be increased when Alprenolol is combined with Caffeine.]
[L03AB09, interferon alfacon-1, The metabolism of Caffeine can be decreased when combined with Interferon alfacon-1.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be decreased when combined with Caffeine.]
[R03CC06, isoetharine, The risk or severity of hypokalemia can be increased when Caffeine is combined with Isoetharine.]
[J04AC01, isoniazid, The serum concentration of Caffeine can be increased when it is combined with Isoniazid.]
[R03CB01, isoproterenol, The serum concentration of Caffeine can be decreased when it is combined with Isoprenaline.]
[C04AA01, isoxsuprine, The risk or severity of adverse effects can be increased when Isoxsuprine is combined with Caffeine.]
[P02CF01, ivermectin, Caffeine may decrease the excretion rate of Ivermectin which could result in a higher serum level.]
[J01FA07, josamycin, The metabolism of Caffeine can be decreased when combined with Josamycin.]
[H01AC01, somatropin, The metabolism of Caffeine can be increased when combined with Somatotropin.]
[L04AC07, tocilizumab, The metabolism of Caffeine can be increased when combined with Tocilizumab.]
[J02AB02, ketoconazole, The metabolism of Caffeine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be decreased when combined with Caffeine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the diuretic activities of Caffeine.]
[V03AC03, deferasirox, The serum concentration of Caffeine can be increased when it is combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Caffeine can be increased when combined with Abatacept.]
[C01CA22, arbutamine, The risk or severity of hypokalemia can be increased when Caffeine is combined with Arbutamine.]
[J01MB02, nalidixic acid, The metabolism of Caffeine can be decreased when combined with Nalidixic acid.]
[C07AG01, labetalol, The risk or severity of adverse effects can be increased when Labetalol is combined with Caffeine.]
[N03AX18, lacosamide, Lacosamide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Caffeine.]
[C01EB21, regadenoson, Caffeine may decrease effectiveness of Regadenoson as a diagnostic agent.]
[N06BA13, armodafinil, The metabolism of Caffeine can be increased when combined with Armodafinil.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be decreased when used in combination with Caffeine.]
[L01EG01, temsirolimus, The metabolism of Caffeine can be decreased when combined with Temsirolimus.]
[V04CC02, magnesium sulfate, Magnesium sulfate may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01BA05, pralatrexate, Caffeine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, Caffeine may decrease the excretion rate of Nilotinib which could result in a higher serum level.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Caffeine.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Caffeine.]
[N05CH01, melatonin, The metabolism of Melatonin can be decreased when combined with Caffeine.]
[C01CA11, mephentermine, The risk or severity of adverse effects can be increased when Mephentermine is combined with Caffeine.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Caffeine.]
[N03AA01, mephobarbital, The serum concentration of Caffeine can be decreased when it is combined with Methylphenobarbital.]
[C01CA09, metaraminol, The risk or severity of adverse effects can be increased when Metaraminol is combined with Caffeine.]
[N06BA03, methamphetamine, The risk or severity of adverse effects can be increased when Metamfetamine is combined with Caffeine.]
[J05AF05, lamivudine, Caffeine may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[N03AA30, metharbital, Metharbital may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, Methimazole may decrease the excretion rate of Caffeine which could result in a higher serum level.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be decreased when combined with Caffeine.]
[N05CA15, methohexital, The serum concentration of Caffeine can be decreased when it is combined with Methohexital.]
[L04AX03, methotrexate, Caffeine may decrease the excretion rate of Methotrexate which could result in a higher serum level.]
[C01CA10, methoxamine, The risk or severity of adverse effects can be increased when Methoxamine is combined with Caffeine.]
[D05BA02, methoxsalen, The metabolism of Caffeine can be decreased when combined with Methoxsalen.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Caffeine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Caffeine.]
[N03AF03, rufinamide, Rufinamide may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Caffeine.]
[C07AB02, metoprolol, The risk or severity of adverse effects can be increased when Metoprolol is combined with Caffeine.]
[C01BB02, mexiletine, The metabolism of Caffeine can be decreased when combined with Mexiletine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Caffeine.]
[N05CD08, midazolam, The therapeutic efficacy of Midazolam can be decreased when used in combination with Caffeine.]
[C01CA17, midodrine, The risk or severity of adverse effects can be increased when Midodrine is combined with Caffeine.]
[J01FA11, miocamycin, The metabolism of Caffeine can be decreased when combined with Miocamycin.]
[L01DB07, mitoxantrone, Caffeine may decrease the excretion rate of Mitoxantrone which could result in a higher serum level.]
[N06BA12, lisdexamfetamine, The risk or severity of adverse effects can be increased when Lisdexamfetamine is combined with Caffeine.]
[C01BD01, amiodarone, The serum concentration of Caffeine can be increased when it is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Caffeine.]
[L04AB05, certolizumab pegol, The metabolism of Caffeine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be decreased when combined with Caffeine.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Caffeine.]
[N05CA02, amobarbital, The serum concentration of Caffeine can be decreased when it is combined with Amobarbital.]
[G03XC01, raloxifene, Caffeine may decrease the excretion rate of Raloxifene which could result in a higher serum level.]
[N03AB05, fosphenytoin, The serum concentration of Caffeine can be decreased when it is combined with Fosphenytoin.]
[L03AB08, interferon beta-1b, The metabolism of Caffeine can be decreased when combined with Interferon beta-1b.]
[N04BC04, ropinirole, The risk or severity of adverse effects can be increased when Caffeine is combined with Ropinirole.]
[J01CF06, nafcillin, The metabolism of Caffeine can be increased when combined with Nafcillin.]
[L04AC03, anakinra, The metabolism of Caffeine can be increased when combined with Anakinra.]
[S01GA01, naphazoline, The risk or severity of adverse effects can be increased when Naphazoline is combined with Caffeine.]
[N06BA01, amphetamine, The risk or severity of adverse effects can be increased when Amphetamine is combined with Caffeine.]
[M04AA03, febuxostat, The serum concentration of the active metabolites of Caffeine can be increased when Caffeine is used in combination with Febuxostat.]
[P02DA01, niclosamide, The metabolism of Caffeine can be decreased when combined with Niclosamide.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Caffeine.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Caffeine.]
[J01XE01, nitrofurantoin, Caffeine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Zaleplon may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA03, norepinephrine, The risk or severity of adverse effects can be increased when Norepinephrine is combined with Caffeine.]
[S01AE02, norfloxacin, The metabolism of Caffeine can be decreased when combined with Norfloxacin.]
[L03AB07, interferon beta-1a, The metabolism of Caffeine can be decreased when combined with Interferon beta-1a.]
[G02CA02, nylidrin, The risk or severity of adverse effects can be increased when Nylidrin is combined with Caffeine.]
[S02AA16, ofloxacin, The metabolism of Caffeine can be decreased when combined with Ofloxacin.]
[J01FA05, oleandomycin, The metabolism of Caffeine can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Caffeine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Caffeine can be increased when combined with Omeprazole.]
[R03CB03, metaproterenol, The risk or severity of adverse effects can be increased when Orciprenaline is combined with Caffeine.]
[N05BA04, oxazepam, The therapeutic efficacy of Oxazepam can be decreased when used in combination with Caffeine.]
[J01MB05, oxolinic acid, The metabolism of Caffeine can be decreased when combined with Oxolinic acid.]
[C07AA02, oxprenolol, The risk or severity of adverse effects can be increased when Oxprenolol is combined with Caffeine.]
[S01GA04, oxymetazoline, The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Caffeine.]
[N05AH05, asenapine, The metabolism of Asenapine can be decreased when combined with Caffeine.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be decreased when used in combination with Caffeine.]
[N05CC05, paraldehyde, Paraldehyde may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA03, pefloxacin, The metabolism of Caffeine can be decreased when combined with Pefloxacin.]
[C07AA23, penbutolol, The risk or severity of adverse effects can be increased when Penbutolol is combined with Caffeine.]
[C04AD03, pentoxifylline, The serum concentration of Caffeine can be increased when it is combined with Pentoxifylline.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Caffeine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Caffeine.]
[N03AA02, phenobarbital, The serum concentration of Caffeine can be decreased when it is combined with Phenobarbital.]
[A08AA01, phentermine, The risk or severity of adverse effects can be increased when Phentermine is combined with Caffeine.]
[N03AB02, phenytoin, The serum concentration of Caffeine can be decreased when it is combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Caffeine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The metabolism of Caffeine can be decreased when combined with Levofloxacin.]
[C08CX01, mibefradil, The metabolism of Caffeine can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Caffeine.]
[C07AA03, pindolol, The risk or severity of adverse effects can be increased when Pindolol is combined with Caffeine.]
[J01MA11, grepafloxacin, The metabolism of Caffeine can be decreased when combined with Grepafloxacin.]
[A03AE01, alosetron, The metabolism of Alosetron can be decreased when combined with Caffeine.]
[L04AC08, canakinumab, The metabolism of Caffeine can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, Caffeine may decrease the excretion rate of Ritonavir which could result in a higher serum level.]
[V03AB21, potassium iodide, Potassium Iodide may decrease the excretion rate of Caffeine which could result in a higher serum level.]
[C10AA08, pitavastatin, Caffeine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.]
[C07AB01, practolol, The risk or severity of adverse effects can be increased when Practolol is combined with Caffeine.]
[N05BA11, prazepam, The therapeutic efficacy of Prazepam can be decreased when used in combination with Caffeine.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Caffeine.]
[C02CA01, prazosin, Caffeine may decrease the excretion rate of Prazosin which could result in a higher serum level.]
[P01BA03, primaquine, The metabolism of Primaquine can be decreased when combined with Caffeine.]
[N03AA03, primidone, The metabolism of Caffeine can be increased when combined with Primidone.]
[M04AB01, probenecid, The serum concentration of Caffeine can be increased when it is combined with Probenecid.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Caffeine.]
[C01BC03, propafenone, The serum concentration of Caffeine can be increased when it is combined with Propafenone.]
[C07AA05, propranolol, The risk or severity of adverse effects can be increased when Propranolol is combined with Caffeine.]
[H03BA02, propylthiouracil, Propylthiouracil may decrease the excretion rate of Caffeine which could result in a higher serum level.]
[C01BA01, quinidine, The serum concentration of Caffeine can be increased when it is combined with Quinidine.]
[P01BC01, quinine, The serum concentration of Caffeine can be increased when it is combined with Quinine.]
[A02BA02, ranitidine, The metabolism of Ranitidine can be decreased when combined with Caffeine.]
[J04AB02, rifampin, The metabolism of Caffeine can be increased when combined with Rifampicin.]
[G02CA01, ritodrine, The risk or severity of adverse effects can be increased when Ritodrine is combined with Caffeine.]
[A07EC01, sulfasalazine, Caffeine may decrease the excretion rate of Sulfasalazine which could result in a higher serum level.]
[N05CA06, secobarbital, The serum concentration of Caffeine can be decreased when it is combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Caffeine.]
[C07AA07, sotalol, The risk or severity of adverse effects can be increased when Sotalol is combined with Caffeine.]
[N03AG01, valproic acid, Valproic acid may increase the excretion rate of Caffeine which could result in a lower serum level and potentially a reduction in efficacy.]
